Changcheng Zheng

16PUBLICATIONS
10CO-AUTHORS
Haematological tumoursGene and molecular therapyAutoimmunityHaematologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 11, 2026
Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study.

|Apr 30, 2026
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study.

|Mar 23, 2026
Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO).

Huiling Yan, Xing Hu, Lijun Zhu

|Feb 04, 2026
A specific FX activator for bleeding treatment in hemophilia with inhibitors: multicenter, open-label, phase 1/2 trials.

Wei Liu, Hu Zhou, Ruibin Huang

|Mar 31, 2025
Real-World Analysis of Clinical Characteristics, Treatment Outcomes, and the Novel Predictive Model for Patients with Thrombotic Thrombocytopenic Purpura (TTP) and TTP-Like Syndrome.

Mengya Lv, Xing Hu, Lijun Zhu

|Aug 05, 2024
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF.

Dan Liu, Juan Tong, Erling Chen

Pageof 3

Frequent Collaborators

8 joint publications

Juan Tong

4 joint publications

Li Zhou

1 joint publications

Xia-Bo Shen

1 joint publications

Jin Xu